Clinical Trials

List clinical trials by disease

The results of your search are listed below. To view the details of a trial or study, click on the "see details >" link. Or start a new search.

Searched for: Brain Cancer. 16 results shown below.

Dose-Intensive Chemotherapy in Combination With Chemoprotected Autologous Stem Cells in Treating Patients With Malignant Gliomas

[Complete title: Dose-Intensive Chemotherapy in Combination with Chemoprotected Autologous Stem Cells for Patients with Malignant Gliomas]
Principal Investigator: Hans-Peter Kiem, MD
Study Number: 2000.00
Phase: I/II

Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma

[Complete title: A Phase II Study of Bendamustine in the Treatment of Recurrent High-Grade Gliomas (Anaplastic Gliomas and Glioblastoma)]
Principal Investigator: Marc Chamberlain, MD
Study Number: 6803
Phase: II

18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors

[Complete title: Cellular Proliferation Imaging Using [18F]fluorothymidine (FLT) Positron Emission Tomography (PET) in Brain Tumors]
Principal Investigator: Jason Rockhill
Study Number: 7754
Phase: NA

Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors (SEED)

[Complete title: The Feasibility of Selecting Patient-Specific Biologically Targeted Therapy with Sorafenib, Everolimus, Erlotinib or Dasatinib for Pediatric Patients with Refractory or Recurrent Brain Tumors]
Principal Investigator: Sarah Leary
Study Number: SC-9006
Phase: Pilot

Exploring Genetic Changes In Pediatric Brain Tumors
Principal Investigator: Sarah Leary
Study Number: SC-B904

DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma

[Complete title: Comprehensive Molecular Analysis of Tumor Samples Derived From Patients With Diffuse Brainstem Glioma - A Pilot Study]
Principal Investigator: J. Russell Geyer, MD
Study Number: CHRMC-B901
Phase: Pilot

A Pilot RCT of the PRISM Intervention for AYAs With Cancer

[Complete title: SC-N114: A Pilot Randomized Controlled Trial of the Promoting Resilience in Stress Management (PRISM) Intervention for Adolescents and Young Adults with Cancer]
Principal Investigator: Abby Rosenberg
Study Number: SC-N114
Phase: Pilot

Radiation Therapy With or Without Temozolomide in Treating Patients With Anaplastic Glioma

[Complete title: RTOG 0834: Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1P/19Q Deleted Anaplastic Glioma: The CATNON Intergroup Trial]
Principal Investigator: George Laramore, MD, PhD
Study Number: 7880
Phase: III

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

[Complete title: RTOG 1205: Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma]
Principal Investigator: George Laramore, MD, PhD
Study Number: 8024
Phase: II

Enrollment on the Childhood Cancer Research Network (CCRN) of the Children s Oncology Group

[Complete title: Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN) and Local Data Collection]
Principal Investigator: Doug Hawkins, MD
Study Number: ACCRN07

Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors

[Complete title: CHRMC Brain Tumor Research Specimen Distribution Protocol including COG-ACNS02B3: A ChildrenÂ’s Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens]
Principal Investigator: J. Russell Geyer, MD
Study Number: ACNS02B3
Phase: NA

Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

[Complete title: Phase I study of CDK 4-6 inhibitor PD-0332991 in children with recurrent, progressive or refractory central nervous system tumors]
Principal Investigator: Sarah Leary
Study Number: PBTC-042
Phase: I

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

[Complete title: Phase II Study of everolimus for recurrent or progressive low-grade gliomas in children]
Principal Investigator: Sarah Leary
Study Number: PNOC001
Phase: II

Vemurafenib in Children With Recurrent/Refractory BRAFV600E-mutant Gliomas

[Complete title: Safety, Phase 0, and Pilot Efficacy Study of vemurafenib, an oral inhibitor of BRAFV600E, in Children with Recurrent/Refractory BRAFV600E-mutant gliomas]
Principal Investigator: Sarah Leary
Study Number: PNOC002
Phase: Pilot

A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma

[Complete title: An Open Label Phase 1b/2 Study of Orally Administered PLX3397 in Combination with Radiation Therapy and Temozolomide in Patients with Newly Diagnosed Glioblastoma]
Principal Investigator: Marc Chamberlain, MD
Study Number: 20131088
Phase: I/II

A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects

[Complete title: Phase I/IIa, 2-Part, Multi-Center, Single-Arm, Open-Label Study to Determine the Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib in Pediatric Subjects Aged 1 Month to <18 Years with Advanced BRAF V600-Mutation Positive Solid Tumors]
Principal Investigator: Sarah Leary
Study Number: SC-4003
Phase: I/II

Select a disease from the list below:

Limit results to studies enrolling:

OR

Search by Keyword, Investigator Name or Study ID#:

Limit results to studies enrolling:

OR

View all studies

Limit results to studies enrolling:

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials